Results for tag: "Stiolto"

Stiolto is a brand of respiratory drugs used to treat chronic obstructive pulmonary disease (COPD). It is a combination of two drugs, tiotropium and olodaterol, which work together to reduce symptoms of COPD such as shortness of breath and wheezing. Stiolto is taken as an inhaler and is available in both a standard and a Respimat inhaler. The Respimat inhaler is designed to deliver a slow, steady dose of the drug over a longer period of time. Stiolto is a relatively new drug on the market, but it has quickly become a popular choice for treating COPD. It is generally well-tolerated and has been shown to improve lung function and reduce COPD symptoms. Companies in the Stiolto market include Boehringer Ingelheim, GlaxoSmithKline, and AstraZeneca. Show Less Read more